Part of the Metabolic, Endocrine & Women’s Disorders Centre
Polycystic ovary syndrome is usually presented as an ovarian problem. It behaves much more like a metabolic one that expresses through the ovaries.
You were told you have cysts on your ovaries, given something to restore a period, and sent away. It worked while you took it.
You have probably also been told to lose weight — by someone who did not explain why losing it is harder for you than for the person who gave the advice.
And the acne, the hair, the exhaustion and the cycle were each treated as separate problems by separate people.
They are not separate problems. They are the same metabolic process expressing in four places.
Answered without the marketing. Where the honest answer is “no” or “not always”, it says so.
It is not only about periods or fertility. The metabolic risk is the part most often left unsaid.
Read the answer →Sometimes, and not always. What actually decides it, and what to assess first.
Read the answer →The insulin picture is central rather than incidental, which is why metabolic screening matters early.
Read the answer →PCOD and PCOS attract more misinformation than almost any other condition we treat.
Read the answer →What the assessment covers and what the formulations actually work on.
Read the answer →The cysts are a finding, not the disease. They are immature follicles that stalled before ovulating — the consequence of the hormonal environment, not its cause. This matters practically: you can have polycystic ovaries on a scan without having PCOS, and you can have PCOS with ovaries that look unremarkable.
What sits underneath, in most patients, is a self-reinforcing loop. Insulin resistance raises circulating insulin; insulin drives the ovary to produce more androgen and lowers the binding protein that would otherwise keep androgen inactive; the resulting androgen excess disrupts follicular maturation and worsens the metabolic picture. Low-grade chronic inflammation runs alongside all of it, further degrading insulin sensitivity.
That loop is why PCOS does not stay in the ovary. It expresses through weight, skin, hair, mood and cycle simultaneously, because it is one process with several outlets. Treating any single outlet without touching the loop holds exactly as long as the treatment does.
Two people with the same diagnosis frequently need different treatment, because the dominant driver differs. Establishing which is loudest is the substance of assessment.
Insulin-led. The most common pattern. Weight that resists the usual measures, particularly central; sugar cravings and post-meal energy crashes; skin tags or darkened skin in the folds. Prediabetes frequently accompanies it, and this is the pattern with the clearest long-term metabolic risk.
Androgen-led. Acne along the jaw and chin, hair thinning at the scalp, unwanted growth on the face or body. Weight may be unremarkable, which is precisely why this pattern is often missed or dismissed as cosmetic.
Inflammation-led. Fatigue disproportionate to sleep, digestive symptoms, sometimes co-existing inflammatory conditions. Standard bloods can look reassuring while the picture is clearly inflammatory.
Thyroid-involved. Hypothyroidism and PCOS co-occur often enough that thyroid function is checked at assessment as standard. Untreated, it will limit what any PCOS treatment can achieve, and it is straightforward to identify.
Most patients are a blend with one dominant. The dominant driver decides what moves first, and it decides what to expect.
The clinical description understates this. What patients describe is a body that stopped responding to the things that used to work — eating carefully and gaining anyway, and being told to try harder by people who have not had to.
The visible symptoms carry their own weight. Hair growth where it is not wanted and hair loss where it is are both, quietly, among the most distressing parts of this condition, and they are routinely treated as vanity rather than symptom.
Then there is the uncertainty about fertility, often arriving years before you intended to think about it, and frequently delivered as an aside during a scan.
PCOS is not an isolated gynaecological condition, and treating it as one misses what matters over a decade.
Metabolic. Insulin resistance progresses. The link with prediabetes and type 2 diabetes is well established, and it is the single strongest argument for treating PCOS in your twenties rather than waiting until fertility makes it urgent.
Endometrial. Cycles that do not ovulate mean the endometrium is not shed regularly. Over years, that matters, and it is a reason we do not treat prolonged absent periods as a cosmetic inconvenience.
Skin. Androgen excess drives sebaceous activity and follicular keratinisation, which is why PCOS and hidradenitis suppurativa co-occur far more often than chance. If you have both, they are not two unrelated problems and should not be treated by two people who never speak.
| Screened at assessment | Because |
|---|---|
| Fasting insulin and glucose | Insulin resistance is the most common driver and the clearest long-term risk |
| Androgen pattern and SHBG | Decides whether skin and hair symptoms are the lead problem |
| Thyroid function | Co-occurs often, and untreated it limits what any PCOS treatment can achieve |
| Inflammatory and digestive picture | Degrades insulin sensitivity and is frequently missed on standard bloods |
| Cycle and ovulation history | Distinguishes anovulatory from irregular, which changes the approach |
Assessment establishes the driver profile before anything is compounded: insulin and metabolic status, androgen pattern, thyroid function, digestion and inflammatory load, cycle history, and what has already been tried and what happened.
Treatment then works on the driver rather than the presenting symptom. In practice that means oral formulations targeting insulin sensitivity and the inflammatory load where those dominate, and the androgen pattern where that does. In Ayurvedic terms this is Agni Deepana and Ama Pachana — correcting digestive and metabolic function, and clearing the inflammatory load that degrades it — which is the same process described from the other side.
Dietary and activity guidance runs alongside the formulations and is complementary, not the treatment itself. We are specific about it rather than issuing a generic list, because the useful changes differ by driver: an insulin-led picture needs different attention from an inflammation-led one.
Where you are on a medication that is working — metformin, a combined pill, spironolactone — we do not ask you to stop it to begin. Reduction, if it becomes appropriate, is a conversation with your prescribing physician once the underlying picture has actually changed.
Metabolic change is slow, and anyone offering fast PCOS results is selling something. What tends to move first is energy, digestion and post-meal stability — often within weeks, and often before anything visible changes.
Skin and hair follow over months, and hair is the slowest of all: scalp density and unwanted growth both track the follicular cycle, so meaningful change is a six-to-twelve-month observation, not a six-week one.
Cycle regularity is typically last. That ordering is counter-intuitive and it is the single most common reason people abandon treatment that is working — they judge by the one marker that moves last.
Where PCOS has run many years with significant metabolic involvement, the realistic goal is sustained control rather than cure. And if you are trying to conceive on a defined timeline, say so at assessment: it changes what is appropriate, and it may mean this is not the right route on its own.
| What changes | When it typically moves | Why that order |
|---|---|---|
| Energy, digestion, post-meal stability | Weeks 2–6 | Insulin sensitivity and inflammatory load respond before anything visible does |
| Acne and skin | Months 2–4 | Sebaceous activity follows androgen change, not the other way round |
| Scalp and unwanted hair | Months 6–12 | Both track the follicular cycle; nothing moves faster than the hair does |
| Weight trend | Months 3–8 | Follows insulin sensitivity rather than calorie restriction alone |
| Cycle regularity | Last, often month 6+ | Ovulation resumes only once the metabolic and androgen picture has actually shifted |
We do not publish a success rate. We have no aggregate figure we can substantiate with a sample size and a method, and until we do we will not put a number on this page.
Cycle regularity and interval. Metabolic markers including insulin and weight trend. Androgenic symptoms — acne, scalp hair, unwanted hair growth. Energy and mood pattern across the cycle.
We do not track follicle counts as a progress measure. The scan is how the diagnosis was reached, not how treatment is judged.
Metabolic and energy changes usually move first. Skin and hair follow over months. Cycle regularity is typically the last thing to settle — judging progress by it alone is the most common reason people stop something that is working.
If you are trying to conceive on a defined timeline, this may not be the right route on its own, and we would say so at assessment rather than after months. Where PCOS has run for many years with significant metabolic involvement, the realistic goal is sustained control rather than cure.